THIS ETF HAS BEEN LIQUIDATED AS OF DECEMBER 2008.
The HealthShares Diagnostics ETF (Ticker: HHD) seeks to replicate as closely as possible, before expenses, the total return performance of the HealthShares Diagnostics Index is comprised of companies engaged in the identification of disease, the visual localization of a disease by way of imaging, the selection of therapeutic agents appropriate for the disease wherever possible and the monitoring of disease progression/therapeutic efficacy. Companies must have a minimum market capitalization greater than $100 million and less than $15 billion for at least two of the three proceeding quarters. Stocks are equally weighted when the fund is formed and then float with the market thereafter. When the weight of an individual stock reaches 15% of the index value it is adjusted down to 10%, and when a stocks falls to 2.5% it is adjusted up to 5%. S&P is the administrator of HealthShares indexes.